Juventas Therapeutics Garners $5,000,000 New Funding
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=265c44d9-512a-4b7b-ba95-de255b8c7bce
Date 11/21/2013
Company Name Juventas Therapeutics
Mailing Address 3615 Superior Avenue Cleveland, OH 44114
Company Description Juventas Therapeutics is a privately held biotechnology company developing a pipeline of regenerative therapies to treat life–threatening diseases. The company’s lead product, Stromal–cell Derived Factor 1 (SDF–1), has been shown to protect and repair tissue following organ–damage in a broad range of pre–clinical disease models.